Did Silvercrest Asset Management Group Llc decreased Its Natus Medical Inc Stake?

Big Money Sentiment increased to 1 in Q3 2018. It has change of 0.11, from 2018Q2’s 0.89. The ratio improved due to Natus Medical Incorporated positioning: 13 sold and 53 reduced. 22 funds took holdings and 44 increased holdings. Investors holded 29.79 million in 2018Q2 but now own 28.55 million shares or 4.17% less.

Aqr Cap Mgmt Ltd Co holds 0% or 28,046 shs in its capital. Ls Invest Advisors Limited Liability invested 0% in Natus Medical Incorporated (NASDAQ:BABY). Alliancebernstein Ltd Partnership has 55,486 shs for 0% of their capital. Millennium Mngmt Llc owns 0% invested in Natus Medical Incorporated (NASDAQ:BABY) for 11,579 shs. Swiss State Bank has 0% invested in Natus Medical Incorporated (NASDAQ:BABY) for 58,400 shs. Wellington Limited Liability Partnership invested in 0.01% or 1.01M shs. Citadel Advsr Limited accumulated 81,961 shs. Moreover, Penn Davis Mcfarland has 0.07% invested in Natus Medical Incorporated (NASDAQ:BABY) for 6,500 shs. Citigroup holds 0% or 10,534 shs. Strs Ohio owns 63,700 shs for 0.01% of their capital. South Dakota Investment Council has 4,200 shs. Moreover, Geode Cap Lc has 0% invested in Natus Medical Incorporated (NASDAQ:BABY). Cutter And Brokerage has 0.21% invested in Natus Medical Incorporated (NASDAQ:BABY) for 16,950 shs. Synovus Fincl Corp holds 133 shs. Fisher Asset Management Ltd Liability invested in 0.02% or 573,991 shs.

Natus Medical Incorporated had 3 insider sales and 0 buys since August 29, 2018. This’s net activity of $3.18 million. 47,600 Natus Medical Incorporated (NASDAQ:BABY) shs with value of $1.75M were sold by Kennedy Jonathan. $494,715 worth of Natus Medical Incorporated (NASDAQ:BABY) shs were sold by GUNST ROBERT A.

Silvercrest Asset Management Group Llc posted reduced Interest in Natus Medical Inc

By clicking the link 000119312519039325 you will find SC 13G/A SEC form submitted by Silvercrest Asset Management Group Llc about Natus Medical Inc.The filler decreased its holding in the stock by -0.90 % for 1,573,241 shares.In another form on December31, 2018 the percentage Silvercrest Asset Management Group Llc holds in Health Care- stock is 4.7%.

After announcing a decrease with $15.87 billion of its Natus Medical Inc ownership the hedge fund looks more negative.

The Health Care is the hedge fund most active sector. Its 12% of Silvercrest Asset Management Group Llc�s US portfolio.

Natus Medical Inc Institutional Holdings

161 investors own Natus Medical Inc says the latest SEC reports. In Q3 2017 the institutional ownership is high, which is Infinity of the outstanding shares. By 832699 shares it is increased. Institutional investors held 30604578. In total 20 funds opened new Natus Medical Inc stakes, 58 increased stakes. There were 32 that closed positions and 70 reduced them.

Here’s the stocks most Significant investors in which it takes place: .

Since Q3 2017 Mariko Gordon Daruma Capital Management Llc is owning 3.24% of its US portfolio or 1385533 shares. The stake that Corsair Capital Management Lp posted worth 2.33% of its portfolio 370133 shares. Further, Pax World Management Llc posted stake worth 1.62% of the manager�s US portfolio. 158480 shares holds CA Pax World Management Llc which is 2.79% of their stock portfolio. The 292897 shares are held by CA Lyon Street Capital Llc. Natus Medical Inc is 4.23% of its portfolio.

Silvercrest Asset Management Group Llc website.

Ticker’s shares touched $26.51 during the last trading session after 11.25% change.Natus Medical Incorporated is downtrending after having declined 12.80% since February 14, 2018. BABY has 3.02M volume or 571.69% up from normal. The stock underperformed the S&P500 by 12.80%.

Natus Medical Incorporated provides newborn care and neurology healthcare services and products worldwide.The firm is worth $885.90 million. It offers services and products used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.Currently it has negative earnings. The company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.

For more Natus Medical Incorporated (NASDAQ:BABY) news brought out recently go to: Nasdaq.com, Nasdaq.com, Nasdaq.com, Businessinsider.com or Nasdaq.com. The titles are as follows: “Chinese scientist who gene-edited babies fired by university – Nasdaq” brought out on January 21, 2019, “Indian food delivery firm Swiggy to supply home essentials – Nasdaq” on February 12, 2019, “J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect – Nasdaq” with a publish date: January 17, 2019, “A newborn baby was found dead in a trash can in an Amazon warehouse restroom – Business Insider” and the last “BABY Makes Bullish Cross Above Critical Moving Average – Nasdaq” with publication date: January 25, 2019.

Natus Medical Incorporated (NASDAQ:BABY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.